Andrew J. Last - Apr 29, 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, Chief Operating Officer
Signature
/s/ Andrew J. Last
Stock symbol
BIO
Transactions as of
Apr 29, 2023
Transactions value $
-$155,973
Form type
4
Date filed
5/1/2023, 12:51 PM
Previous filing
Sep 7, 2022
Next filing
Jun 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +1K +32.13% $0.00 4.11K Apr 29, 2023 Direct F1, F2
transaction BIO Bio-Rad A Common Stock Tax liability -$156K -346 -8.41% $450.79 3.77K Apr 29, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Options Exercise $0 -1K -50% $0.00 1K Apr 29, 2023 Bio-Rad A Common Stock 1K $0.00 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 8.8470 and 20.7590 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022 and 03/31/2023, respectively.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.